Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1:2021:20-0220.
doi: 10.1530/EDM-20-0220. Online ahead of print.

Primary hepatic neuroendocrine tumor

Affiliations

Primary hepatic neuroendocrine tumor

Le Tuan Linh et al. Endocrinol Diabetes Metab Case Rep. .

Abstract

Summary: Primary hepatic neuroendocrine tumor (PHNET) is a rare type of neuroendocrine tumor (NET) that is also a primary hepatic tumor. Patients are present with almost no specific clinical symptoms and typically present with negative test results and atypical imaging characteristics; therefore, the differentiation of PHNET from other types of primary hepatic masses can be very difficult. In this article, we describe a case of PHNET that mimicked a liver helminth infection in a 57-year-old man. The diagnosis of PHNET in this patient was challenging, and the final diagnosis was based on imaging, histopathology features, and long-term follow-up.

Learning points: An uncommon type of neuroendocrine tumor (NET) is a primary hepatic neuroendocrine tumor (PHNET). Primary hepatic neuroendocrine tumors are rare NET lesions found in the liver, characterized by non-specific clinical and imaging results, which can be easily confused with other liver lesions, including HCC and parasitic lesions. To have a conclusive diagnosis and classification, a mixture of many medical assessment techniques, such as imaging, gastrointestinal endoscopy, nuclear medicine, anatomy, including histopathology, and immunohistochemistry, is essential.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Upper abdominal MRI revealed lesions in the VII segment (white arrow) and IV segment (white arrowhead) of the liver. (A) Hyperintense lesions on T2-weighted image. (B) Hypointense lesions on T1-weighted image. (C) Lesions were hyperintense on diffusion-weighted image.
Figure 2
Figure 2
The lesions were heterogeneous enhancement (white arrow and black arrowhead).
Figure 3
Figure 3
The second abdominal ultrasound. Well-defined hyperechoic lesion with and hypoechoic border identified the seventh segment of the liver.
Figure 4
Figure 4
(A) First abdominal MRI result: T1-weighted, fat-suppressed image showing a 22 × 28 mm nodule in segment VII of the liver (white arrow) and a small, faint lesion in segment IV (white arrowhead). (B) Second abdominal MRI images: T1-weighted, fat-suppressed imaging revealed that liver lesions increased in size after 4 months, with the segment VII mass measuring at 40 × 31 mm (white arrow) and the lesion in segment IV clearly visible and 15 × 23 mm in size (white arrowhead).
Figure 5
Figure 5
Second abdominal MRI images, two lesions (white arrow and white arrowhead) showed restricted diffusion. (A) Lesions were hyperintense on diffusion-weighted image. (B) Lesions were hypointense on apparent diffusion coefficient (ADC) map.
Figure 6
Figure 6
Second abdominal MRI images. (A) lesions were poorly enhancement on arterial phase. There was no washout sign of lesions on the portal phase (B) or delayed phase images (C).
Figure 7
Figure 7
Histopathology: (A) Hematoxylin-eosin staining ×10 magnification. Tumor tissue, bordered by normal liver tissue. The tumor-aligned cells suggested a glandular structure. (B) Hematoxylin-eosin staining ×100 magnification. The tumor cells are uniform, with large, round, or oval nuclei, fine, granular chromatin, and lying to one side, with no abnormal mitotic activity or necrosis.
Figure 8
Figure 8
Immunohistochemistry (A, ×40) Tumor cells are positive for CD56. (B, ×20) Tumor cells are positive for CK marker. (C, ×40) Tumor cells are positive for marker P53. (D, ×20) synaptophysin-positive cells. (E, ×20) Tumor cells are negative with chromogranin marker. (F, ×40) Ki67 index 20%.
Figure 9
Figure 9
PET-CT with 18F-FDG. (A) CT and (B) PET-CT scans. Two hypometabolic hepatic lesions were observed, and no hypermetabolic lesions were identified in other organs.
Figure 10
Figure 10
Abdominal and chest CT images obtained 15 months after the last check-up. (A) Axial, non-enhanced CT image showing a hypoattenuating lesion in the fourth segment of the liver (white arrowhead) and most of the right lobe (white arrow), with an unclear boundary. (B) Axial, non-enhanced CT image showing a calcified mass in the liver (arrow). (C) Axial CT image in the arterial phase, showing the heterogeneous enhancement of the lesions (white arrow and white arrowhead). (D) Axial CT image in the venous phase, revealing lesions with signs of washout in the venous phase (white arrow and white arrowhead). (E) Coronal CT images in the venous phase, showing complete thrombosis of the right branch of the portal vein (white arrow). (F) No lesions were observed on thoracic CT.

References

    1. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S.The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 2010. 39 707–712. (10.1097/MPA.0b013e3181ec124e) - DOI - PubMed
    1. Song JE, Kim BS, Lee CH.Primary hepatic neuroendocrine tumor: a case report and literature review. World Journal of Clinical Cases 2016. 4 243–247. (10.12998/wjcc.v4.i8.243) - DOI - PMC - PubMed
    1. Camargo ÉS, Viveiros Mde Mde M, Corrêa Neto IJ, Robles L, Rezende MB.Primary hepatic carcinoid tumor: case report and literature review. Einstein 2014. 12 505–508. (10.1590/S1679-45082014RC2745) - DOI - PMC - PubMed
    1. Li W, Zhuang BW, Wang Z, Liao B, Hong LY, Xu M, Lin XN, Xie XY, Lu MD, Chen LD, et al. Case report of contrast-enhanced ultrasound features of primary hepatic neuroendocrine tumor: a CARE-compliant article. Medicine 2016. 95 e3450. (10.1097/MD.0000000000003450) - DOI - PMC - PubMed
    1. Kellock T, Tuong B, Harris AC, Yoshida E.Diagnostic imaging of primary hepatic neuroendocrine tumors: a case and discussion of the literature. Case Reports in Radiology 2014. 2014 156491. (10.1155/2014/156491) - DOI - PMC - PubMed

LinkOut - more resources